Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes

Abstract

Aims/hypothesis We compared the symptoms of hypoglycaemia induced by insulin detemir (NN304) (B29Lys(ε-tetradecanoyl),desB30 human insulin) and equally effective doses of neutral protamine Hagedorn (NPH) insulin in relation to possible differential effects on hepatic glucose production and peripheral glucose uptake. Methods After overnight intravenous infusion of soluble human insulin 18 participants with type 1 diabetes received subcutaneous injections of NPH insulin or insulin detemir (0.5 U/kg body weight) on separate occasions in random order. During the ensuing gradual development of hypoglycaemia cognitive function and levels of counter-regulatory hormones were measured and rates of endogenous glucose production and peripheral glucose uptake continuously evaluated using a primed constant infusion of [6,6-2 H 2 ] glucose. The study was terminated when plasma glucose concentration had fallen to 2.4 mmol/l or had reached a minimum at a higher concentration. Results During the development of hypoglycaemia no difference between the two insulin preparations was observed in symptoms or hormonal responses. Significant differences were seen in rates of glucose flux. At and below plasma glucose concentrations of 3.5 mmol/l suppression of endogenous glucose production was greater with insulin detemir than with NPH insulin, whereas stimulation of peripheral glucose uptake was greater with NPH insulin than with insulin detemir. Conclusions/interpretation In participants with type 1 diabetes subcutaneously injected insulin detemir exhibits relative hepatoselectivity compared with NPH insulin, but symptoms of hypoglycaemia and hormonal counterregulation are similar.

Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

“…For example, dimerization of the insulin molecule and a thyroxylinsulin analog, which binds to thyroid hormone-binding proteins, has shown relative hepatopreferential activity, but these insulins apparently have not been further developed for use in humans (28-30). The binding to albumin by insulin detemir has also been used to explain a mild hepatopreferential action of that insulin analog under hypoglycemic conditions (31). Additionally, the insulin precursor, proinsulin, has demonstrated a greater effect on EGP than GDR (32,33).…”

Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients

“…Mean plasma insulin concentrations were 564 Ϯ 170 and 493 Ϯ 149 pmol/ liter (P ϭ 0.4) with GLP-1 and saline, respectively. Values are higher than usual fasting levels because insulin detemir is albumin bound, which causes higher plasma concentrations of free and bound insulin detemir than equivalent doses of neutral protamine Hagedorn insulin (18).…”

Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

“…For the primary endpoint, hypoglycaemic symptom score (HSS) at nadir, using an SD of 13.5 [19] and a significance level of 5%, it was calculated that 26 completers were required to yield sufficient power (83%) to detect an eight point difference between IDeg and IGlar. Twenty-eight patients were enrolled to allow for dropouts.…”